Loading...
Imatinib may be ABL to improve anti-angiogenic therapy
We recently reported that neuropilin 1 (NRP1) drives angiogenesis by promoting extracellular matrix signaling in endothelial cells via ABL1 kinase. Imatinib targets this pathway in pathological angiogenesis and may provide a novel opportunity for anti-angiogenic therapy of age-related macular degene...
Saved in:
| Published in: | Mol Cell Oncol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Taylor & Francis
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4905228/ https://ncbi.nlm.nih.gov/pubmed/27308396 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/23723548.2014.968034 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|